Skip to main content
Clinical Trials/NCT06241248
NCT06241248
Completed
N/A

Evaluation of the Performance of a New Rapid Bacteremia Test in the Intensive Care Patient

University Hospital, Bordeaux1 site in 1 country110 target enrollmentMay 13, 2024
ConditionsSepsis

Overview

Phase
N/A
Intervention
Rapid sepsis diagnostic test
Conditions
Sepsis
Sponsor
University Hospital, Bordeaux
Enrollment
110
Locations
1
Primary Endpoint
Comparison between OCEAN test and gold standard
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

Sepsis is a serious health problem with a very high mortality in the ICU. The most important treatment for sepsis is the fastest possible antibiotic therapy. The identification of the pathogen responsible for sepsis is essential to propose an appropriate antibiotic treatment. However, the diagnosis of bacteremia by blood culture requires an average delay of 48 to 72 hours. The new test proposed by OCEAN Dx makes it possible to identify a bacteremia in a few hours. The main objective of the study is to evaluate the performance of the rapid identification test for bacteremia proposed by OCEAN Dx compared to a classic diagnostic strategy using blood cultures.

Detailed Description

Sepsis is a worldwide problem. The World Health Organization estimates that around 49 million people suffer from sepsis each year. It is responsible for an unacceptable number of deaths, estimated at around 11 million. The severity of sepsis is not only related to the infection itself, but often to a too late diagnosis and an important heterogeneity in the management of patients. The identification of the pathogen responsible for sepsis is currently based on the positivity of bacteriological samples, particularly blood cultures. However, the diagnosis of bacteremia by blood cultures requires an average delay of 48 to 72 hours, which is not conducive to rapid adaptation of antibiotic therapy. The test proposed by OCEAN Dx offers the identification of a bacteremia in a few hours thanks to the recognition of the bacterial DNA in the patient's blood. The main objective of the study is to evaluate the performance of the rapid identification test for bacteremia offered by OCEAN Dx in comparison with a classical diagnostic strategy using blood cultures.

Registry
clinicaltrials.gov
Start Date
May 13, 2024
End Date
June 10, 2025
Last Updated
3 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years of age admitted to an intensive care unit (ICU) with a suspected or documented infection requiring blood cultures.

Exclusion Criteria

  • Patient under 18 years of age
  • Pregnant or breastfeeding woman
  • Patient of legal age, under guardianship or deprived of liberty
  • Not affiliated to a social security regime or not benefiting from such a regime.

Arms & Interventions

Ocean Test

The OCEAN Dx tests for the diagnosis of sepsis will be performed on 9 milliliters of blood collected at the patient's bedside.The sample will be collected at the same time as the blood cultures are taken. The blood tubes will then be transported to OCEAN Dx laboratories.

Intervention: Rapid sepsis diagnostic test

Outcomes

Primary Outcomes

Comparison between OCEAN test and gold standard

Time Frame: 1 month after inclusion day

Agreement between the OCEAN Dx test results and blood cultures, gold standard of bacteriemia identification.

Secondary Outcomes

  • Delay of positivity(1 month after inclusion day)
  • Positivity rate(1 month after inclusion day)
  • Impact of Ocean test on antibiotic therapy adaptation.(1 month after inclusion day)

Study Sites (1)

Loading locations...

Similar Trials